Enavatuzumab
CAS: 1062149-33-0
Ref. TM-T76865
| 1mg | 235.00 € | ||
| 5mg | 629.00 € | ||
| 10mg | 1,005.00 € | ||
| 25mg | 1,488.00 € | ||
| 50mg | 1,941.00 € |
Estimated delivery in United States, on Tuesday 29 Apr 2025
Product Information
Name:
Enavatuzumab
Synonyms:
- PDL-192
- PDL192
- Anti-TNFRSF12A/TWEAKR/CD266 Reference Antibody
- ABT-361
- ABT361
Description:
Enavatuzumab (PDL192) is a humanized monoclonal antibody targeting TWEAK receptor with anti-tumor activity.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Purity:
>95%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T76865 Enavatuzumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
